📰 Leukemia News
Page 87 - Leukemia News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Leukemia. Real-time updates on events, politics, business and more.
December 2, 2023
The Make-A-Wish Foundation is helping make a 11-year-old Scarsdale resident Ross Silverberg's dreams come true.
December 2, 2023
The Food and Drug Administration approved Jaypirca for patients with chronic lymphocytic leukemia or small lymphocytic lymphoma who received two or more lines of therapy.
December 2, 2023
Eli Lilly said the health regulator gave the new approval to the drug for the treatment of chronic lymphocytic leukemia (CLL), a type of cancer in which the bone marrow makes too many of certain white blood cells. Jaypirca was first given accelerated approval by the FDA on Jan. 27 for the treatment of mantle cell lymphoma.
December 2, 2023
Eli Lillys drug Jaypirca has received a second approval from the US FDA for the treatment of chronic lymphocytic leukemia (CLL), adding to its previous approval for mantle cell lymphoma (MCL).
December 2, 2023
New film American Symphony set out to portray an artist on the brink of a major breakthrough – then came the bombshell diagnosis
December 1, 2023
A nonprofit is on a mission to make a special dream come true for a little girl from Taylorsville who's spent most of her life battling cancer.
November 30, 2023
Following promising study results, a Biologics License Application has been filed with the FDA for obe-cel (obecabtagene autoleucel), a CAR-T cell therapy for patients with relapsed/refractory (r/r) adult B-cell acute lymphoblastic leukemia (ALL).
November 30, 2023
The FDA announced rare instances of secondary diseases or cancers from CAR-T cell therapy, though this is not the first time that oncology treatments have been associated with secondary diseases.
November 30, 2023
From overlooked gum disease to suspicious lesions, oral health can provide a critical window into broader medical concerns.
November 30, 2023
A discusses the FDA’s investigation into the possible association between CAR-T cell therapy and secondary T-cell malignancies.